Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy ResearchNOW IN
    Review

    A Review of Integrative Plant-Based Approaches for the Management of Hashimoto Thyroiditis

    Nishanthi Gunasekar1★, Swedha Jaganathan1, Athirai Pagalavan Muthukumaravel1, Buvan Raj Ayyanar1, Surya Ramalingam1, Hariprasath Pachaiyappan1★ Corresponding author

    1. 1Department of Pharmaceutics, School of Pharmacy, Sri Balaji Vidyapeeth (Deemed to be University), Pondicherry, INDIA.

    CORRESPONDENCE

    Nishanthi Gunasekar

    Ms. Nishanthi G Department of Pharmaceutics, School of Pharmacy, Sri Balaji Vidyapeeth (Deemed to be University), Pillayarkuppam, Pondicherry-607402, INDIA.

    nishanthi@sbvu.ac.in

    Received: 14-10-2025; Revised: 03-11-2025; Accepted: 29-12-2025.

    Volume 18, Issue 2 · pp. 270–278 · PUBLISHED Apr-Jun 2026 · DOI: 10.5530/pres.20260090

    View on Pharmacogn. Res. original site ↗

    ABSTRACT

    Hashimoto Thyroiditis (HT) is one of the chronic autoimmune diseases of the thyroid gland which is characterized by the gradual destruction of the thyroid and the development of hypothyroidism. It occurs mainly in women and is caused by genetic dispositions, malfunctioning of immune system, environmental factors and imbalance of hormones. The levothyroxine drug therapy stabilizes thyroid hormone clearance but does not complete recovery of dissimilar symptoms or recovery of the immune dysfunction. This review examines the nature of plant-based and nutritional intervention as an add-on in the management of HT. An in-depth analysis of recent studies was done in regards to the plant-based therapies, phytochemicals and nutritional interventions applied to Hashimoto Thyroiditis. A special focus was made on medicinal plants like Withania somnifera, Curcuma longa, Nigella sativa, and Prunella vulgaris, and findings of preclinical, clinical and emergent nano-phytomedicine studies. Evidence suggests that there is the possibility that bioactive phytochemicals have immunomodulatory, antioxidant and anti-inflammatory activity. Adaptogens and nutritional components are effective to stabilize a Hypothalamic-Pituitary-Thyroid (HPT) axis and normalize stress-induced endocrine sequelae. Nano-phytomedicine therapy has been found to be a promising clinical method towards enhancing the bioavailability and specificity. Weaknesses are lack of uniformity, minimal clinical trial evidence as well as the possibility of drug interactions associated with herbs. Nutritional and plant-based therapy is an alternative and complementary form of treatment to conventional HT. The direction of the future is to work in the arrangement of genomics, microbiome science, and digital health with a view to enabling personalized strategies. There are also therapeutic opportunities in targeting the gut-thyroid-immune axis using pre and probiotics and polyphenol-rich diets. Collectively, such strategies offer a potentially bright future with regards to safer, customized, and more efficient HT management.

    KEYWORDS

    0% READ

    FULL TEXT

    INTRODUCTION

    Hashimoto Thyroiditis (HT) is non-malignant autoimmune disorder characterised by immune mediated destruction of the thyroid gland, resulting from an aberrant immune response against self-thyroid tissue. It was first noted by Hakaru Hashimoto a Japanese scientist in the year 1912 and it is currently considered to be the most frequent cause of hypothyroidism in iodine adequate areas (Ritter, 2025). HT is considerably more prevalent in women than in men, with an estimated female-to-male incidence ratio of approximately 7:1. The aetiology of HT has both genetics (HLA-DR, CTLA-4, FOXP3 and PTPN22 among many others) and environmental influences (viral infection, iodine excess, nutrient deficiency, chronic stress among others). These cause imbalance in the immune state resulting in autoimmune thyroid and progressive hypothyroidism. The determination of HT is a manifestation of a complex cause of genetic vulnerability and exposure to the environment. The pathogenesis of the disease is characterized by abnormal manifestation of activities of T-lymphocytes and B-lymphocytes, the process of inflammation, and the gradual destruction of the thyroid tissue. The microscopic examination of Hashimoto thyroiditis demonstrates fibrotic alteration in the gland, the atrophy of the thyroid follicles and massive lymphoplasmacytic infiltration. Clinical manifestations of HT are; constipation, goitre, intolerance to cold, fatigue, and weight gain. Some patients even can briefly enter a hyperthyroid stage (halitoxicosis), because of hormone spillage of the damaged follicles (Altemimi et al., 2024). The recommended treatment is the continuation of levothyroxine, yet a lot of patients continue to feel tired, the quality of life is lower even though the level of their hormones returned to normal. It is due to this that complementary plant-based therapies, which aim at restoring immune balance and supporting the whole-body thyroid function, have become famous (Li et al., 2024).

    METHODOLOGY

    A comprehensive search for literature was conducted using many major databases, including Google Scholar, PubMed, Scopus, Web of Science, ScienceDirect, and Wiley Online Library. Relevant reviews, theses, dissertations, and peer-reviews were evaluated. Results were compiled to emphasise immunological processes, clinical characteristics, and dietary and plant-based treatments for Hashimoto thyroiditis.

    Immunological Basis and Autoimmune Mechanism

    Hashimoto Thyroiditis arises when the immune system maladaptively loses immunological tolerance to the thyroid gland and attacks the thyroid gland. The condition is also more vulnerable in women due to X-chromosome inactivation and genetic susceptibility that includes such markers as HLA-DR, CTLA-4, PTPN22, and FOXP3 (Tomer et al., 2009). This inflammatory response may be due to environmental factors such as stress, infections, and excessive amounts of iodine or starvation in an individual who has a genetic predisposition to these factors. The attack is mainly carried out by Th1 and Th17 subsets of the CD4+ T helper cells; they produce pro-inflammatory cytokines, including TNF-α, IL-17 and IFN-γ, which kill the thyroid cell, and lead to fibrosis. In addition, the granzyme and perforin are employed by the CD8+ cytotoxic T cells, directly damaging the thyroid tissue (Heward et al., 1997). The creation of anti-TPO and anti-Tg autoantibodies that are expressed in at least 90 percent of HT patients and leads to the manifestation of antibody-mediated inflammation is another contribution of the B cells and the plasma cells. These immune responses make impair thyroid function, hence leading to fibrosis, follicular atrophy, formation of germinal centres and lymphoplasmacytic infiltration (Wesley H. Brooks, 2009). Advancement often leads to subclinical or clearly visible hypothyroidism, whose main symptoms are fatigue, weight gain, intolerance to the cold, constipation, and goitre, although, early stages may be asymptomatic. Hashitoxicosis is a temporary hyperthyroid condition that occurs in five to fifteen percent of the patients (Antonelli et al., 2015). The low quality of life of many patients remains even after the levothyroxine therapy and the restoration of the hormone levels to normal, which can be a sign of immune dysregulation, beyond the hormone deficiency. Moreover, studies show that intestinal dysbiosis and oxidative stress, i.e., with high gut permeability, low Lactobacillus and Bifidobacterium and high presence of harmful bacteria, contribute to the imbalance of the immune system as well. All these changes can enhance autoimmunity because of suppressing the regulatory T cells (Saranac et al., 2011). These mutual mechanisms explain to a greater degree the potential of plant-based therapies to promote thyroid repair, reduce inflammation, and restore immunological balance and thus collectively demonstrate that the HT is a complex, autoimmune disease.

    Endocrine and Hormonal Dysregulation in HT

    Hashimoto thyroiditis reflects the gradual autodestructive process of thyroid gland operation and leads to the impairment of the secretion of such vital thyroid hormones as Thyroxine (T4) and Triiodothyronine (T3) that help to control metabolism, temperature, mood, and energy levels (Gaitonde DY, et al., 2012). First of all, many patients stay euthyroid and without symptoms. But as the damage progresses, higher values of Thyroid Stimulating Hormone (TSH) are experienced and this advancement indicates transition to subclinical or overt hypothyroidism (Rayman et al., 2022). Cold intolerance, fatigue, gain weight, dyspepsia, dry skin, constipation, bradycardia and cognitive slowing are all the common symptoms of hypothyroidism. Hashitoxicosis, the interim transient hyperthyroid phase that results from the release of preformed thyroid hormones due to follicular destruction, and may occur in approximately 5-15% of individuals (Smith et al., 2016).

    Other causes of endocrine disorder include

    • Micronutrient deficiencies such as selenium and iron deficiencies.
    • Sustained chronic inflammation of low-grade.
    • Bisphenol A (BPA) and phthalates are endocrine-disrupting chemicals that disrupt hormone synthesis, metabolism and receptor binding.

    Such effects can be alleviated by adopting plant-based treatments that contain high levels of antioxidants, selenium substances as well as polyphenols, which have been found to:

    • Prevent thyroid oxidative stress.
    • And optimize the peripheral conversion of T4 to T3.
    • Defeat the endocrine-disrupting chemicals effect.
    • Promote endocrine and general metabolic status (Chaker et al., 2016).

    Considering these multifactorial elements of hormonal imbalance, integrative practices that target the immune and endocrine system may be beneficial to Hashimoto thyroiditis patients, in conjunction with the conventional use of the hormone replacement.

    Clinical Presentation and Diagnostic Biomarkers

    Clinical presentation

    Hashimoto thyroiditis is a progressive condition that is already worsening by the time a person recognises it has begun. At an early phase, most patients are euthyroid, or the levels of thyroid hormones remain intact despite the assault by their immune system (Ott et al., 2011). As the ailment proceeds with its progress, the patients might become hypothyroid, thereby indicating that the thyroid gland generates insufficient quantities of hormones needed to saturate the body. Usually, the symptoms are listed in the Figure 1.

    Figure 1: Illustrates the Symptoms of HT.

    Patients might have a goiter (visible or palpable swelling of the thyroid), or a non-painful swelling of the neck because of enlargement of the thyroid. The goiter can be the reason of the difficulty of swallowing, tightness of neck, or hoarseness, which is observed rarely. A small portion (5-15% of the patients) can develop hyperthyroid symptoms such as anxiousness, palpitations and heat intolerance in the short period due to leaking thyroid hormones into damaged tissue in the form of a short period called as Hashitoxicosis (Garber et al., 2012). HT affects mostly middle age women although it is possible in men, children or elderly people. The condition is 7 to 10 times frequent among women (Ott et al., 2011). Some of the patients show no symptoms and are diagnosed when the patients are undergoing routine blood tests. Nevertheless, despite appropriate treatment, a large number of persons claim to feel continuously exhausted or have low quality of life, which demonstrates that treatment of HT is not limited to substituting the hormones. (Biondi et al., 2008) The various types of biomarkers which are used for diagnosis is listed in the below Table 1 and the limitations of conventional treatment is listed in the Table 2.

    Table 1: Diagnostic Biomarkers.
    Test TypeSpecific TestKey Findings in HTPurpose
    Thyroid Function Tests (Chiovato et al., 2014)TSHElevatedIndicates hypothyroidism due to low thyroid hormones
    Thyroid Function Tests (Chiovato et al., 2014)Free T4, Free T3Low or low-normalConfirms overt or subclinical hypothyroidism
    Thyroid Autoantibodies (Al-Rabia et al., 2017)Anti-TPO antibodies>90% of HT patientsMost specific antibody for HT
    Thyroid Autoantibodies (Al-Rabia et al., 2017)Anti-Tg antibodies~80% of HT patientsSupports autoimmune etiology
    Imaging (Rago et al., 2008)Ultrasound of thyroidHypoechogenic, heterogeneous, vascular, pseudonodulesStructural diagnosis; helpful for nodules
    Emerging Biomarkers (Pan et al., 2023)CXCL10, IL-17, Tregs markersUnder researchPotential future diagnostic tools
    Table 2: Conventional Management and its Limitation (Wiersinga WM, et al., 2014).
    TreatmentPurposeLimitations
    Levothyroxine (T4)Restores the levels of thyroid hormonesDoesn't address the autoimmune process; even with normal TSH levels, 10-15% of people still have symptoms.
    Combination Therapy (T4 + T3)Aims to improve the management of symptomsClinical evidence is conflicting; there is a chance that T3 will cause anxiety or palpitations.
    Surgical InterventionUsed in severe, uncommon cases (like large goitre)Permanent and invasive; fails to address systemic immune dysfunction
    Immunosuppressants (experimental)Lessens inflammation in study environmentsNot common because of possible adverse effects; only used in research and experiments

    The Scientific Shift Toward Plant-Based Medicine in Autoimmune Disorders

    Natural cures are becoming an in-demand method of treatment in cases of autoimmune disease because they are safer and more holistic compared to prescription medication. This section plunges into the possibilities of using medicinal herbs as well as phytochemicals to control immune- based thyroid diseases. It is an intermingling of lore and science.

    Phytomedicine Approaches for Autoimmune Disorders

    The autoimmune diseases, including Hashimoto thyroiditis, rheumatoid arthritis, lupus, multiple sclerosis and type 1 diabetes, develop as a result of the immune system getting a misguided understanding of what identifies a portion of the bodily tissues, which then has an immunological response to itself. Although traditional medications such as corticosteroids and immunosuppressants may minimise the symptoms, regular application of such medications leads to major side effects in most cases (Luo et al., 2023). Phytomedicine is the use of bioactive compounds of plants that appears to be a natural gain without many adverse effects. Most medicinal plants like Withania somnifera, Curcuma longa, Nigella sativa, Zingiber officinale, and Prunella vulgaris have good immunomodulatory, antioxidant and anti-inflammatory effects (Panda et al., 1999; Bamosa et al., 2009). The effect of these botanicals is to control pro-inflammatory cytokines such as TNF-α and IL-6, mop up malicious free radicals as well as re-equilibrate the immune responses that are usually excessive in autoimmune diseases. Unlike synthetic immunosuppressants, the phytochemicals flavonoids, terpenoids and alkaloids of these herbs are multi-targeted, and tend to be better tolerated by patients (Ghaffari-Saravi et al., 2024). They would however need stronger research to be translated to clinical use, such as a standard dose, longer-term toxicity and controlled human trials (Huang et al., 2024).

    PHARMACOLLOGICALLY ACTIVE PLANTS IN THE MANAGEMENT OF HASHIMOTO THYROIDITIS

    Medicinal plants such as Withania somnifera, Curcuma longa, Nigella sativa and Prunella vulgaris contribute to Hashimoto thyroiditis since they reduce inflammation and autoantibodies levels, increase synthesis of thyroid hormones and protect against oxidative stress. Antioxidant and immune-modulating properties of other herbs such as Bacopa monnieri and Camellia sinensis can be applied as a means of to regulate the outcomes of the thyroid dysfunction mechanism and its associated symptoms (Chaudhary et al., 2023; Tripathi et al., 1984). The pharmacological effects of plants and their mechanism of action are shown in Table 3.

    Table 3: Plants and Their Pharmacological effects and Mechanism of Action relevant in Hashimoto Thyroiditis.
    Plant NameKey Bioactive CompoundsPharmacological Effects Relevant to HTMechanism of Action
    Withania somnifera (Panda et al., 1999)WithanolidesImmunomodulatory, anti-inflammatoryBalances Th1/Th2 response, lowers cortisol, reduces TNF-α and IL-6
    Curcuma longa (Singh et al., 2023)CurcuminAnti-inflammatory, antioxidantInhibits NF-κB signaling, scavenges ROS, suppresses cytokines
    Nigella sativa (Bamosa et al., 2010)ThymoquinoneAntioxidant, thyroid hormone regulationEnhances T3/T4 levels, reduces lipid peroxidation, boosts glutathione
    Prunella vulgaris (Ma et al., 2025)Rosmarinic acid, flavonoidsImmunosuppressive, anti-inflammatoryInhibits lymphocyte proliferation, reduces autoantibody production
    Camellia sinensis (Chaudhary et al., 2023)EGCG (epigallocatechin gallate)Antioxidant, cytoprotectiveReduces oxidative stress in thyroid tissue, modulates immune response
    Commiphora mukul (Tripathi et al., 1984)GuggulsteroneThyroid-stimulating activityIncreases iodine uptake, enhances T3 conversion
    Zingiber officinale (Singh et al., 2023)Gingerols, shogaolsAnti-inflammatory, metabolic regulationLowers CRP, improves gut health (gut-thyroid axis), reduces TNF-α
    Bacopa monnieri (Kar et al., 2002)BacosidesNeuroprotective, thyroid supportEnhances T4 levels, supports antioxidant enzymes

    Mechanistic Insight: How Herbal Compounds in the body

    Withania somnifera, Curcuma longa, Nigella sativa, Commiphora mukul, and Prunella vulgaris are a reasonable choice as medicinal plants that can promote the thyroid role of the Hashimoto thyroiditis by decreasing inflammation and reactive oxygen species, TAAs, converting T4 to T3, and immune response regulation. Adaptogens, such as Rhodiola rosea and Eleutherococcus senticosus, further promotes HPA balance and cortisol decreasing effects, whereas herbs, which are supportive of the appropriate direction, such as Bacopa monnieri, Camellia sinensis, Allium sativum, and Zingiber officinale may present antioxidant, neuroprotective, as well as gut-protective effects (Ghaffari-Saravi et al., 2024).

    Nutritional and Adaptogenic Support

    Adaptogens and nutritional compounds have the potential to significantly contribute to the health of the thyroid, in a natural way. The section shows the reduction of inflammation and stress dysfunction balance brought on by certain foods and herbs. They pay importance to long-term support stratergis regarding the diet.

    Dietary Phytochemicals

    Medicinal plants such as Withania somnifera, Curcuma longa, Nigella sativa and Prunella vulgaris contribute to Hashimoto thyroiditis since they reduce inflammation and autoantibodies levels, increase synthesis of thyroid hormones and protect against oxidative stress. Antioxidant and immune-modulating properties of other herbs such as Bacopa monnieri and Camellia sinensis can be applied as a means of to regulate the outcomes of the thyroid dysfunction mechanism as mentioned in the Table 4 (Panda et al., 1999; Bamosa et al., 2010; Lagoumintzis et al., 2023).

    Table 4: Phytochemicals and their dietary sources (Panda S, et al., 1999; Ma Y, et al., 2025).
    Phytochemical categoryExamples of compoundSources
    FlavonoidsQuercetin, Myricetin, Apigenin, RutinOnions, citrus, parsley, berries
    Phenolic acidsCurcumin, Rosmarinic acidTurmeric, rosemary, mint
    IsoflavonesGenisteinSoy, legumes
    PolyphenolsEGCG, Catechins, Chlorogenic acidGreen tea, coffee, apples
    Alkaloids and TerpenesVarious (e.g., thymoquinone, limonene)Black seed, citrus peel, medicinal herbs

    Role of Adaptogens in Stress Linked Thyroid Dysfunction

    This autoimmune disease is caused by the malfunction of the immune system due to which it produces autoantibodies, such as anti-Thyroid Peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg), that destroy thyroid cells and damage hormone production. Some medicinal plants provide natural and multi-target therapy of HT. Withania somnifera (Ashwagandha) aids in stabilizing the Hypothalamic Pituitary Thyroid (HPT) axis and guarding thyroid insofar as it is vulnerable to stressful alteration (Panda et al., 1999). Curcumin and Curcuma longa (Turmeric) are antioxidants and inflammation modulators and Nigella sativa has the properties that reduce thyroid autoantibody (Singh et al., 2023). Zingiber officinale (Ginger) helps the hormone metabolism and circulations- all aspects of help that may assist in general thyroid support (Garber et al., 2012). Chronic stress, also affects the Hypothalamus Pituitary Adrenal (HPA) axis by increasing cortisol levels that inhibit T4 to T3 hormone conversion. Rhodiola rosea, Panax ginseng and Ocimum sanctum are adaptogenic herbs that can rebalance the cortisol level, maintain the dialogue between the adrenal and thyroid glands, and protect the thyroid tissues against the oxidative and autoimmune destruction caused by the antioxidant and anti-inflammatory effects of these substances (Panossian et al., 2010) as in Figure 2.

    Figure 2: Illustrates the multi target mechanisms of adaptogens in stress linked thyroid dysfunction (Panossian et al., 2010; Richard et al., 2016).

    Nano-Phytomedicine for Targeted Thyroid Support

    The field of nano-phytomedicine utilizing phytochemical treatments and nanotechnology are enhancing the management of Hashimoto thyroiditis using plant extracts. Anti-inflammatory, Immunomodulatory, and antioxidant properties, overcoming pharmacokinetic barriers and having a more potent therapeutic effect.

    Nano-phytomedicine is a new strategy to find solutions to the drawbacks existing in the management of Hashimoto Thyroiditis (HT) disease by the integration of the use of conventional herbal medicine and nanotechnology. A substantial number of plant-derived compounds have shown a therapeutical potential but poor absorption and unselective effect within the body has limited their clinical utilization. To enhance the delivery and guarantee that active constituents are delivered to the thyroid gland in a focused way and maintained there, nanocarriers were introduced, e.g., liposomes, polymeric nanoparticle and silica-based systems (Sahare et al., 2025). Preclinical models have shown that in recent years, nano-encapsulation enhanced stability, absorption, and tissue specific uptake of diverse phytochemicals. This can cause more accurate regulation of immune reactions and the oxidative stress in the thyroid, which constitute the main aspect of pathogenesis of HT. Most interestingly, there are nanocarriers that can simultaneously deliver phytoconstituents and gene-silencing agents, e.g. CIITA-siRNA to inhibit aberrant immune activation at the tissue site (thyroid), with minimal side effects occurring elsewhere in the host (Khan et al., 2022). The new methods of delivery are an up-and-coming avenue of therapy. Though, human trials are still very preliminary or not done at all, nano-phytomedicine has potential to realize precise and multi-mode treatment of autoimmune thyroid disorder such as HT, that consists of the compounds and their mechanism discussed in preclinical studies.

    CHALLENGES IN HERBAL THERAPY OF HT

    To have plant-based therapies widely accepted, clinical evidence plays a key role. This section highlights human studies, safety of use and regulatory issues of bringing the herbal treatment to practice. It deals with bench to beside issue.

    Insufficient Standardisation: There is inconsistency in dosage since concentration and potency of active compounds in herbs changes with plants species and plant harvest and manufacturing methods.

    Lack of adequate Clinical Data: Well-conducted, huge clinical studies that state the safety and efficiency of the herbal therapies especially on Hashimoto thyroiditis are lacking.

    Drug-Herb Interactions: Through the metabolism of hormones or absorption, some herbal products are likely to counteract thyroid medication like levothyroxine.

    Inadequate Bioavailability: Most phytochemicals such as curcumin or thymoquinone are not well-absorbed or get metabolized easily in the body unless they are enhanced with nano-formulations or systems.

    Personal Variability: Herbal treatment cannot be personalised easily since the immune system, gut microbiome and genetic factors of the patients also differ.

    Inadequate Regulation: In contrast to drugs, the herbal products are often less rigorously regulated, which creates the potential of the contamination, adulteration, or mislabelling (Luo et al., 2024).

    PERSONALIZED PLANT BASED PROTOCOLS AND FUTURE SCOPE

    The future of Hashimoto Thyroiditis (HT) treatment is the field of integrative and personalized medicine that uses the synergy between nutritional science, biotechnology, and digital technology. Genomics, metabolomics, and microbiome profiling will guide precision nutrition so that fully personalized diet and nutraceutical protocol could be recommended based on each individual synthetic genome and biochemical landscape (Lagoumintzis et al., 2023). In parallel, digital health solutions and AI-based wearables can facilitate monitoring and tracking the symptoms in real-time, daily dietary records, and integration with the lab data to enable periodic patient intervention strategy adaptation to their lifestyle changes. Meanwhile, the application of clinical trials on a larger scale is in demand to justify certain protocols of using plants as well as establish the preferred ranges within the spectrum of micronutrients on the one hand and take into consideration extremely increased inter-individual variability of HT responses on the other hand (De Toro-Martín et al., 2017). In addition, the recent advance in gut-thyroid-immune integration has suggested the possibility of incorporating prebiotics, probiotics, and polyphenols containing foods in addition to manipulating intestinal microbiota and immune tolerance, which is likely to enhance clinical outcomes in HT patients (Yoo et al., 2024).

    CONCLUSION

    Hashimoto Thyroiditis (HT) is a complicated interconnection between autoimmunity, hormonal imbalances, and environmental factors and usually progress to chronic manifestations that have not disappeared even with standard thyroid hormone replacement. Although levothyroxine is the gold standard treatment of restoring hormone levels, it will remain an insufficient treatment concerning the pathogenic role of immune-mediated thyroid destruction and the systemic imbalances that underlie HT. There has been evidence that is growing in support of the use of plant-based medicine, phytochemicals and nutrition interventions as possible complimentary to conventional treatment. Plant and extraction products of Withania somnifera, Curcuma longa, Nigella sativa and Prunella. vulgaris show strong immunomodulatory, anti-inflammatory and antioxidant activities with the potential to act directly on the pathophysiological processes of HT. Stress management-related hormonal imbalances that involve the hypothalamic-Pituitary-Thyroid (HPT) and Pituitary-adrenal (HPA) axes may also be significant with adaptogens (such as Rhodiola rosea and Panax ginseng). Nano-phytomedical innovations also augment bioavailability and accuracy of herbal therapies, allowing targeting of specific tissues and hopefully minimising the systemic side effects. In spite of this optimistic development, there are still many barriers. These are the absence of standardised dosing, few large clinical trials, the possibility of herb-drug interactions and variation in patient responses in relation to their genetic, microbial and metabolic differences. Besides, existing regulatory systems on herbal products tend to be inadequate in terms of achieving congruent quality and safety. Further evolution of the discipline of HT management is an integrative and individualistic approach-an addition of what was gained in traditional field of endocrinology, evidence-based phytomedicine and functional nutrition and digital health tools. Bringing in microbiome-based therapy, diets rich in polyphenols, and real-time tracking of symptoms will enable dynamic, tailor-made approaches to care. As research has been growing, it is hoped that holistic protocols will be developed that can bring the thyroid hormone levels back under control and restore health to the immune system and overall long-term quality of life in individuals living with Hashimoto thyroiditis.

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

    1. 1.Al-Rabia, M. W.. Correlation of thyroid antibodies with TSH. Pakistan Journal of Pharmaceutical Sciences, T3 and T4 hormones in patients diagnosed with autoimmune thyroid disorders. 2017;30.GOOGLE SCHOLAR
    2. 2.Altemimi, A. B.; Farag, H. A.; Salih, T. H.; Awlqadr, F. H.; Al-Manhel, A. J.; Vieira, I. R. et al. Application of nanoparticles in human nutrition: A review. Nutrients. 2024;16:636.GOOGLE SCHOLAR
    3. 3.Antonelli, A.; Ferrari, S. M.; Corrado, A.; Di Domenicantonio, A.; Fallahi, P.. Autoimmune thyroid disorders. Autoimmunity Reviews. 2015;14(2):174–180. https://doi.org/10.1016/j.autrev.2014.10.016DOIGOOGLE SCHOLAR
    4. 4.Bamosa, A. O.; Kaatabi, H.; Lebdaa, F. M.; Elq, A.-M. A.; Al-Sultanb, A.. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian Journal of Physiology and Pharmacology. 2010;54(4):344–354.GOOGLE SCHOLAR
    5. 5.Biondi, B.; Cooper, D. S.. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews. 2008;29(1):76–131. https://doi.org/10.1210/er.2006-0043DOIGOOGLE SCHOLAR
    6. 6.Brooks, W. H.. X chromosome inactivation and autoimmunity. Clinical Reviews in Allergy and Immunology. 2010;39(1):20–29. https://doi.org/10.1007/s12016-009-8167-5DOIGOOGLE SCHOLAR
    7. 7.Caturegli, P.; De Remigis, A.; Rose, N. R.. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmunity Reviews. 2014;13(4–5):391–397. https://doi.org/10.1016/j.autrev.2014.01.007DOIGOOGLE SCHOLAR
    8. 8.Chaker, L.; Wolters, F. J.; Bos, D.; Korevaar, T. I. M.; Hofman, A.; van der Lugt, A. et al. Thyroid function and the risk of dementia: The Rotterdam Study. Neurology. 2016;87(16):1688–1695. https://doi.org/10.1212/WNL.0000000000003227DOIGOOGLE SCHOLAR
    9. 9.Chaudhary, P.; Mitra, D.; Das Mohapatra, P. K.; Oana Docea, A.; Mon Myo, E.; Janmeda, P. et al. Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications. Arabian Journal of Chemistry. 2023;16(5):Article 104680. https://doi.org/10.1016/j.arabjc.2023.104680DOIGOOGLE SCHOLAR
    10. 10.Chiovato, L.; Lapi, P.; Fiore, E.; Tonacchera, M.; Pinchera, A.. Thyroid autoimmunity and female gender. Journal of Endocrinological Investigation. 1993;16(5):384–391. https://doi.org/10.1007/BF03348863DOIGOOGLE SCHOLAR
    11. 11.de Toro-Martín, J.; Arsenault, B. J.; Després, J.-P.; Vohl, M.-C.. Precision nutrition: A review of personalized nutritional approaches for the prevention and management of metabolic syndrome. Nutrients. 2017;9(8):Article 913. https://doi.org/10.3390/nu9080913DOIGOOGLE SCHOLAR
    12. 12.Gaitonde, D. Y.; Rowley, K. D.; Sweeney, L. B.. Hypothyroidism: An update. South African Family Practice. 2012;54(5):384–390.GOOGLE SCHOLAR
    13. 13.Garber, J. R.; Cobin, R. H.; Gharib, H.; Hennessey, J. V.; Klein, I.; Mechanick, J. I. et al. & American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Endocrine Practice. 2012;18(6):988–1028. https://doi.org/10.4158/EP12280.GLDOIGOOGLE SCHOLAR
    14. 14.Ghaffari-Saravi, F.; Jokar, A.. Herbal remedies for hypothyroidism: A systematic review and meta-analysis. Caspian Journal of Internal Medicine. 2024;16(1):1–8. https://doi.org/10.22088/cjim.16.1.1DOIGOOGLE SCHOLAR
    15. 15.Heward, J.; Gough, S. C.. Genetic susceptibility to the development of autoimmune disease. Clinical Science. 1997;93(6):479–491. https://doi.org/10.1042/cs0930479DOIGOOGLE SCHOLAR
    16. 16.Huang, S.; Ziros, P. G.; Chartoumpekis, D. V.; Psarias, G.; Duntas, L.; Zuo, X. et al. Traditional Chinese medicine for Hashimoto’s thyroiditis: Focus on selenium and antioxidant phytochemicals. Antioxidants. 2024;13(7):Article 868. https://doi.org/10.3390/antiox13070868DOIGOOGLE SCHOLAR
    17. 17.Jothie Richard, E.; Illuri, R.; Bethapudi, B.; Anandhakumar, S.; Bhaskar, A.; Chinampudur Velusami, C. et al. Anti-stress Activity of Ocimum sanctum: Possible Effects on Hypothalamic-Pituitary-Adrenal Axis. Phytotherapy Research. 2016;30(5):805–814. https://doi.org/10.1002/ptr.5584DOIGOOGLE SCHOLAR
    18. 18.Kar, A.; Panda, S.; Bharti, S.. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice. Journal of Ethnopharmacology. 2002;81(2):281–285. https://doi.org/10.1016/S0378-8741(02DOIGOOGLE SCHOLAR
    19. 19.Khan, F.; Shariq, M.; Asif, M.; Siddiqui, M. A.; Malan, P.; Ahmad, F.. Green nanotechnology: Plant-mediated nanoparticle synthesis and application. Nanomaterials. 2022;12(4):Article 673. https://doi.org/10.3390/nano12040673DOIGOOGLE SCHOLAR
    20. 20.Lagoumintzis, G.; Patrinos, G. P.. Triangulating nutrigenomics, metabolomics and microbiomics toward personalized nutrition and healthy living. Human Genomics. 2023;17(1):Article 109. https://doi.org/10.1186/s40246-023-00561-wDOIGOOGLE SCHOLAR
    21. 21.Li, J.; Huang, Q.; Sun, S.; Zhou, K.; Wang, X.; Pan, K. et al. Thyroid antibodies in Hashimoto’s thyroiditis patients are positively associated with inflammation and multiple symptoms. Scientific Reports. 2024;14(1):Article 27902. https://doi.org/10.1038/s41598-024-78938-7DOIGOOGLE SCHOLAR
    22. 22.Luo, J.; Xu, L.; Zhou, Y.; Yan, T.; Shao, Y.; Yang, D. et al. Regulating the inner helmholtz plane with a high donor additive for efficient anode reversibility in aqueous Zn-ion batteries. Angewandte Chemie. 2023;135(21):Article e202302302.GOOGLE SCHOLAR
    23. 23.Luo, J.; Zhou, L.; Sun, A.; Yang, H.; Zhang, P.; Liu, K. et al. Herbal medicine for Hashimoto’s thyroiditis: A systematic review and network meta-analysis. Journal of Ethnopharmacology. 2024;323:Article 117663. https://doi.org/10.1016/j.jep.2023.117663DOIGOOGLE SCHOLAR
    24. 24.Ma, Y.; Du, H.; Zheng, S.; Zhou, Z.; Zhang, H.; Ma, Y. et al. High-Entropy Approach vs. traditional Doping Strategy for Layered Oxide Cathodes in Alkali-Metal-Ion Batteries: A Comparative Study. Energy Storage Materials. 2025;79:Article 104295. https://doi.org/10.1016/j.ensm.2025.104295DOIGOOGLE SCHOLAR
    25. 25.Ott, J.; Promberger, R.; Kober, F.; Neuhold, N.; Tea, M.; Huber, J. C. et al. Hashimoto’s thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: A prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid. 2011;21(2):161–167. https://doi.org/10.1089/thy.2010.0191DOIGOOGLE SCHOLAR
    26. 26.Pan, M.; Wei, X.; Xiang, X.; Liu, Y.; Zhou, Q.; Yang, W.. Targeting CXCL9/10/11-CXCR3 axis: An important component of tumor-promoting and antitumor immunity. Clinical and Translational Oncology. 2023;25(8):2306–2320. https://doi.org/10.1007/s12094-023-03126-4DOIGOOGLE SCHOLAR
    27. 27.Panda, S.; Kar, A.. Withania somnifera and Bauhinia purpurea in the regulation of circulating thyroid hormone concentrations in female mice. Journal of Ethnopharmacology. 1999;67(2):233–239. https://doi.org/10.1016/S0378-8741(99DOIGOOGLE SCHOLAR
    28. 28.Panossian, A.; Wikman, G.. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-Protective activity. Pharmaceuticals. 2010;3(1):188–224. https://doi.org/10.3390/ph3010188DOIGOOGLE SCHOLAR
    29. 29.Panossian, A. G.; Efferth, T.; Shikov, A. N.; Pozharitskaya, O. N.; Kuchta, K.; Mukherjee, P. K. et al. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Medicinal Research Reviews. 2021;41(1):630–703. https://doi.org/10.1002/med.21743DOIGOOGLE SCHOLAR
    30. 30.Pistollato, F.; Masias, M.; Agudo, P.; Giampieri, F.; Battino, M.. Effects of phytochemicals on thyroid function and their possible role in thyroid disease. Annals of the New York Academy of Sciences. 2019;1443(1):3–19. https://doi.org/10.1111/nyas.13980DOIGOOGLE SCHOLAR
    31. 31.Rago, T.; Vitti, P.. Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules. Best Practice & Research. Clinical Endocrinology & Metabolism. 2008;22(6):913–928. https://doi.org/10.1016/j.beem.2008.09.016DOIGOOGLE SCHOLAR
    32. 32.Rayman, M. P.. The importance of selenium to human health. The Lancet. 2000;356(9225):233–241. https://doi.org/10.1016/S0140-6736(00DOIGOOGLE SCHOLAR
    33. 33.Ritter, K.. A literature-informed nutrition patient communication toolkit for Hashimoto’s thyroiditis.GOOGLE SCHOLAR
    34. 34.Rudrapal, M.; Mishra, A. K.; Rani, L.; Sarwa, K. K.; Zothantluanga, J. H.; Khan, J. et al. Nanodelivery of dietary polyphenols for therapeutic applications. Molecules. 2022;27(24):Article 8706. https://doi.org/10.3390/molecules27248706DOIGOOGLE SCHOLAR
    35. 35.Sahare, P.; Ruiz-Manriquez, L. M.; Anguiano, B.; Banerjee, A.; Pathak, S.; Duttaroy, A. K. et al. Recent advances in nanomedicine for the diagnosis and therapy of thyroid disorders. 3 Biotech. 2025;15(3):Article 67. https://doi.org/10.1007/s13205-025-04234-4DOIGOOGLE SCHOLAR
    36. 36.Sahoo, D. K.; Roy, A.; Chainy, G. B. N.. Protective effects of vitamin E and curcumin on L-thyroxine-induced rat testicular oxidative stress. Chemico-Biological Interactions. 2008;176(2–3):121–128. https://doi.org/10.1016/j.cbi.2008.07.009DOIGOOGLE SCHOLAR
    37. 37.Saranac, L.; Zivanovic, S.; Bjelakovic, B.; Stamenkovic, H.; Novak, M.; Kamenov, B.. Why is the thyroid so prone to autoimmune disease?. Hormone Research in Paediatrics. 2011;75(3):157–165. https://doi.org/10.1159/000324442DOIGOOGLE SCHOLAR
    38. 38.Singh, S.; Semwal, B. C.; Sharma, H.; Sharma, D.. Impact of phytomolecules with nanotechnology on the treatment of inflammation. Current Bioactive Compounds. 2023;19(10):122–148. https://doi.org/10.2174/1573407219666230807150030DOIGOOGLE SCHOLAR
    39. 39.Smith, T. J.; Hegedüs, L.. Graves’ disease. The New England Journal of Medicine. 2016;375(16):1552–1565. https://doi.org/10.1056/NEJMra1510030DOIGOOGLE SCHOLAR
    40. 40.Tatiya-Aphiradee, N.; Chatuphonprasert, W.; Jarukamjorn, K.. Ethanolic Garcinia mangostana extract and α-mangostin improve dextran sulfate sodium-induced ulcerative colitis via the suppression of inflammatory and oxidative responses in ICR mice. Journal of Ethnopharmacology. 2021;265:Article 113384. https://doi.org/10.1016/j.jep.2020.113384DOIGOOGLE SCHOLAR
    41. 41.Tomer, Y.; Huber, A.. The etiology of autoimmune thyroid disease: A story of genes and environment. Journal of Autoimmunity. 2009;32(3–4):231–239. https://doi.org/10.1016/j.jaut.2009.02.007DOIGOOGLE SCHOLAR
    42. 42.Tripathi, Y. B.; Malhotra, O. P.; Tripathi, S. N.. Thyroid stimulating action of Z-guggulsterone obtained from Commiphora mukul. Planta Medica. 1984;50(1):78–80. https://doi.org/10.1055/s-2007-969626DOIGOOGLE SCHOLAR
    43. 43.Wiersinga, W. M.. Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism. Nature Reviews. Endocrinology. 2014;10(3):164–174. https://doi.org/10.1038/nrendo.2013.258DOIGOOGLE SCHOLAR
    44. 44.Yoo, S.; Jung, S.-C.; Kwak, K.; Kim, J.-S.. The role of prebiotics in modulating gut microbiota: Implications for human health. International Journal of Molecular Sciences. 2024;25(9):Article 4834. https://doi.org/10.3390/ijms25094834DOIGOOGLE SCHOLAR

    Cite this article

    SELECT FORMAT

    Gunasekar, N., Jaganathan, S., Muthukumaravel, A. P., Ayyanar, B. R., Ramalingam, S., & Pachaiyappan, H. (2026). A Review of Integrative Plant-Based Approaches for the Management of Hashimoto Thyroiditis. Pharmacognosy Research, 18(2), 270–278. https://doi.org/10.5530/pres.20260090